808 research outputs found
Celiac Disease-Case Report
Abstract Celiac disease is an immune-mediated systemic disorder with a genetic predisposition. The availability of more specific serology tests showed that celiac disease is more common than previously suspected and that many patients do not demonstrate specific clinical or even histological sings. We present a case of celiac disease with the unset at 5 years, with recurrent episodes of diarrhea, weight loss and anemia. The serology tests showed a high level of IgA tissue transglutaminase antibodies, exceeding 10 times the upper limit but the intestinal biopsy showed normal size villi, intact surface epithelium and a lymphoplasmacytic infiltrate at chorionic level (Marsh 1). The diagnosis of celiac disease was confirmed by resolution of symptoms and normal tissue transglutaminase antibodies level, six month after starting the gluten free diet
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Calcitonin gene-related peptide (CGRP) is a neuropeptide with a pivotal role in the pathophysiology of migraine.
Blockade of CGRP is a new therapeutic target for patients with migraine. CGRP and its receptors are distributed not
only in the central and peripheral nervous system but also in the cardiovascular system, both in blood vessels and
in the heart. We reviewed the current evidence on the role of CGRP in the cardiovascular system in order to
understand the possible short- and long-term effect of CGRP blockade with monoclonal antibodies in migraineurs.
In physiological conditions, CGRP has important vasodilating effects and is thought to protect organs from
ischemia. Despite the aforementioned cardiovascular implication, preventive treatment with CGRP antibodies has
shown no relevant cardiovascular side effects. Results from long-term trials and from real life are now needed
A narrative review of central nervous system involvement in acute leukemias.
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked DownloadAcute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each year more successful therapies are implemented. However, in a subset of cases the overall survival (OS) is still exceptionally low due to the infiltration of leukemic cells in the central nervous system (CNS) and the subsequent formation of brain tumors. The CNS involvement is more common in acute lymphocytic leukemia (ALL), than in adult acute myeloid leukemia (AML), although the rates for the second case might be underestimated. The main reasons for CNS invasion are related to the expression of specific adhesion molecules (VLA-4, ICAM-1, VCAM, L-selectin, PECAM-1, CD18, LFA-1, CD58, CD44, CXCL12) by a subpopulation of leukemic cells, called "sticky cells" which have the ability to interact and adhere to endothelial cells. Moreover, the microenvironment becomes hypoxic and together with secretion of VEGF-A by ALL or AML cells the permeability of vasculature in the bone marrow increases, coupled with the disruption of blood brain barrier. There is a single subpopulation of leukemia cells, called leukemia stem cells (LSCs) that is able to resist in the new microenvironment due to its high adaptability. The LCSs enter into the arachnoid, migrate, and intensively proliferate in cerebrospinal fluid (CSF) and consequently infiltrate perivascular spaces and brain parenchyma. Moreover, the CNS is an immune privileged site that also protects leukemic cells from chemotherapy. CD56/NCAM is the most important surface molecule often overexpressed by leukemic stem cells that offers them the ability to infiltrate in the CNS. Although asymptomatic or with unspecific symptoms, CNS leukemia should be assessed in both AML/ALL patients, through a combination of flow cytometry and cytological analysis of CSF. Intrathecal therapy (ITT) is a preventive measure for CNS involvement in AML and ALL, still much research is needed in finding the appropriate target that would dramatically lower CNS involvement in acute leukemia.
Keywords: Acute leukemias; central nervous system involvement (CNS involvement); clinical management; pathophysiology.Iuliu Hatieganu University-School of Doctoral Studies (PCD 2019-2021)
Romanian Government
Ion Chiricuta Oncology Institute Cluj Napoca
European Economic Spac
Production of He-4 and (4) in Pb-Pb collisions at root(NN)-N-S=2.76 TeV at the LHC
Results on the production of He-4 and (4) nuclei in Pb-Pb collisions at root(NN)-N-S = 2.76 TeV in the rapidity range vertical bar y vertical bar <1, using the ALICE detector, are presented in this paper. The rapidity densities corresponding to 0-10% central events are found to be dN/dy4(He) = (0.8 +/- 0.4 (stat) +/- 0.3 (syst)) x 10(-6) and dN/dy4 = (1.1 +/- 0.4 (stat) +/- 0.2 (syst)) x 10(-6), respectively. This is in agreement with the statistical thermal model expectation assuming the same chemical freeze-out temperature (T-chem = 156 MeV) as for light hadrons. The measured ratio of (4)/He-4 is 1.4 +/- 0.8 (stat) +/- 0.5 (syst). (C) 2018 Published by Elsevier B.V.Peer reviewe
BOALA KIKUCHI-FUJIMOTO – PROBLEME DIAGNOSTICE
Boala Kikuchi este o afecţiune rară, benignă şi autolimitată, de etiologie necunoscută, care ar trebui inclusă în
algoritmul diagnostic al adenopatiei cervicale. Diagnosticul de certitudine este histopatologic, modifi cările
specifi ce fi ind necroza paracorticală ganglionară, histiocitele cu nuclei în formă de semilună şi numeroşii corpi
apoptotici. Se prezintă cazul unui pacient de 13 ani cu diagnosticul de boală Kikuchi, afecţiune rar descrisă la
vârsta pediatrică
SPINNING TOP URETHRA ŞI DISFUNCŢIA MICŢIONALĂ LA COPIL
Disfuncţia micţională este o manifestare clinică comună vârstei pediatrice. Este frecvent asociată cu infecţia
urinară recurentă, constipaţia cronică şi refl uxul vezicoureteral.
Scopul lucrării este de a evalua existenţa unei asocieri între simptomele disfuncţiei micţionale şi aspectul
cistografi c de spinning top urethra (STU).
Material şi metodă. Studiul s-a efectuat în Clinica Pediatrie III Cluj Napoca, în perioada ianuarie 2005–
decembrie 2009. S-au luat în studiu un număr de 105 pacienţi cu simptomatologie de disfuncţie micţională,
care au fost împărţiţi în două loturi în funcţie de prezenţa sau nu a STU. Pacienţii au fost investigaţi clinic şi
imagistic prin ultrasonografi e renourinară şi uretrocistografi a micţională retrogradă.
Rezultate. STU a fost prezentă într-un procent de 57,1%, fi ind mai frecventă la sexul feminin. Urgenţa la
micţiune (82,5%) şi incontinenţa urinară (75,3%) sunt factori independenţi asociaţi statistic semnifi cativ cu
aspectul de STU. La pacienţii cu disfuncţie micţională şi STU, infecţia urinară recurentă este un factor
independent asociat cu spinning top urethra.
In concluzie, la pacienţii cu disfuncţie micţională, aspectul cistografi c de STU, este mai frecvent întâlnit la
sexul feminin şi se asociază statistic semnifi cativ cu simptomele disfuncţiei micţionale şi infecţia urinară
recurentă
An Overview and Comparison of Technical Debt Measurement Tools
There are numerous commercial tools and research prototypes that offer support for measuring technical debt. However, different tools adopt different terms, metrics, and ways to identify and measure technical debt. These tools offer diverse features, and their popularity / community support varies significantly. Therefore, (a) practitioners face difficulties when trying to select a tool matching their needs; and (b) the concept of technical debt and its role in software development is blurred. We attempt to clarify the situation by comparing the features and popularity of technical debt measurement tools, and analyzing the existing empirical evidence on their validity. Our findings can help practitioners to find the most suitable tool for their purposes, and researchers by highlighting the current tool shortcomings.acceptedVersionPeer reviewe
Effects of prophylactic ibuprofen and paracetamol administration on the immunogenicity and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugated vaccine (PHiD-CV) co-administered with DTPa-combined vaccines in children: An open-label, randomized, controlled, non-inferiority trial
Prophylactic paracetamol administration impacts vaccine immune response; this study (www.clinicaltrials.gov: NCT01235949) is the first to assess PHiD-CV immunogenicity following prophylactic ibuprofen administration. In this phase IV, multicenter, open-label, randomized, controlled, non-inferiority study in Romania (November 2010–December 2012), healthy infants were randomized 3:3:3:1:1:1 to prophylactically receive immediate, delayed or no ibuprofen (IIBU, DIBU, NIBU) or paracetamol (IPARA, DPARA, NPARA) after each of 3 primary doses (PHiD-CV at age 3/4/5 months co-administered with DTPa-HBV-IPV/Hib at 3/5 and DTPa-IPV/Hib at 4 months) or booster dose (PHiD-CV and DTPa-HBV-IPV/Hib; 12–15 months). Non-inferiority of immune response one month post-primary vaccination in terms of percentage of infants with anti-pneumococcal antibody concentrations ≥0.2 µg/mL (primary objective) was demonstrated if the upper limit (UL) of the 98.25% confidence interval of difference between groups (NIBU vs IIBU, NIBU vs DIBU) was <10% for ≥7/10 serotypes. Immunogenicity and reactogenicity/safety were evaluated, including confirmatory analysis of difference in fever incidences post-primary vaccination in IBU or DIBU group compared to NIBU. Of 850 infants randomized, 812 were included in the total vaccinated cohort. Non-inferiority was demonstrated for both comparisons (UL was <10% for 9/10 vaccine serotypes; exceptions: 6B [NIBU], 23F [IIBU]). However, fever incidence post-primary vaccination in the IIBU and DIBU groups did not indicate a statistically significant reduction. Prophylactic administration (immediate or delayed) of paracetamol decreased fever incidence but seemed to reduce immune response to PHiD-CV, except when given only at booster. Twenty-seven serious adverse events were reported for 15 children; all resolved and were not vaccination-related
SERS-Based Evaluation of the DNA Methylation Pattern Associated With Progression in Clonal Leukemogenesis of Down Syndrome
Here we show that surface-enhanced Raman scattering (SERS) analysis captures the relative hypomethylation of DNA from patients with acute leukemia associated with Down syndrome (AL-DS) compared with patients diagnosed with transient leukemia associated with Down syndrome (TL-DS), an information inferred from the area under the SERS band at 1005 c
CGRP and migraine from a cardiovascular point of view: What do we expect from blocking CGRP?
Calcitonin gene-related peptide (CGRP) is a neuropeptide with a pivotal role in the pathophysiology of migraine. Blockade of CGRP is a new therapeutic target for patients with migraine. CGRP and its receptors are distributed not only in the central and peripheral nervous system but also in the cardiovascular system, both in blood vessels and in the heart. We reviewed the current evidence on the role of CGRP in the cardiovascular system in order to understand the possible short- and long-term effect of CGRP blockade with monoclonal antibodies in migraineurs. In physiological conditions, CGRP has important vasodilating effects and is thought to protect organs from ischemia. Despite the aforementioned cardiovascular implication, preventive treatment with CGRP antibodies has shown no relevant cardiovascular side effects. Results from long-term trials and from real life are now needed
- …